Why Turnaround Time Is a Clinical and Financial Issue
Turnaround time (TAT) — the interval from specimen collection to final result delivery — is one of the three metrics that define whether a lab partnership is working. The other two are cost per reportable result and reject rate. But TAT is the one patients feel directly.
For STI testing specifically, the clinical stakes are high. Studies consistently show that same-day or next-day result delivery drives meaningfully higher treatment initiation rates. When patients wait 3–5 days for results — and often don't receive a proactive notification — a significant share never return to initiate treatment. In a sexual health context, that's both a public health failure and a missed billing event for your clinic.
The financial impact compounds. Slow TAT drives rush surcharges (labs charge 1.5–2× for next-day expediting), increases patient no-show rates for follow-up visits, and triggers staff overhead for result chasing that doesn't appear on any invoice. A lab with a quoted price of $18/test and a 5-day TAT may actually cost more than a lab at $22 with a 24-hour guarantee — once all the downstream friction is priced in.
Before you can manage TAT, you need to understand what actually drives it.
The Four Stages of STI Test Turnaround Time
Clinicians and operations managers often treat TAT as a single number. It isn't. It's the cumulative result of four distinct phases — each with its own failure modes and optimization levers.
Phase 1: Collection
The clock starts when the specimen is collected. But collection errors — wrong transport media, insufficient volume, incorrect labeling, temperature mishandling at the clinic site — can add hours or days to total TAT because they trigger rejection downstream. A specimen that leaves your clinic incorrectly collected will fail QC at the lab, generating a rejection notice and forcing a redraw that resets the entire clock.
Collection is entirely within your clinic's control. Staff training, standardized collection kits from your lab partner, and a posted quick-reference for each specimen type (urine vs. swab, rectal vs. urethral) can reduce collection-driven rejects to near zero.
Phase 2: Transport
Transport is the most variable phase — and the most underappreciated. It encompasses courier pickup windows, routing schedules, storage conditions during transit, and the time specimens spend in a courier staging area before departure. In markets where labs are more than 100 miles from the clinic, transport alone can account for 12–24 hours of total TAT.
Transport delays are compounded by batching. Most courier services run fixed routes with pickup windows — if you miss the 3 PM window, your specimens sit until the next day's run. Labs that have invested in local courier partnerships or offer courier pickup guarantees of 4 hours or less materially reduce this phase.
Phase 3: Processing
Processing — actual laboratory analysis — is where the test happens. For NAAT (nucleic acid amplification testing), the standard platform for CT/NG/TV panels, processing time itself is not the bottleneck. Modern NAAT platforms run in 90–180 minutes. The bottleneck is when processing starts: labs that batch specimens and run assays twice per day will have a specimen sit for up to 12 hours before it's even loaded onto the instrument.
High-throughput reference labs typically run NAAT assays on a continuous basis during business hours, with final runs at end-of-day. A specimen that arrives at 2 PM at a well-run lab may be processed by 5 PM, with results available by 6 PM. The same specimen at a lower-throughput lab may sit overnight and not be processed until the following morning's batch.
Phase 4: Reporting
Final result delivery — from the lab's LIS to your EHR or ordering portal — is the shortest phase but still introduces meaningful delay if the integration isn't real-time. Labs using manual PDF fax transmission can add 1–4 hours of reporting latency even after the result is finalized. Demand bidirectional HL7 or FHIR integration, or at minimum an API-driven results portal with push notifications. Any lab quoting you in 2026 that still delivers results by fax is not optimizing for your operations.
TAT Benchmarks by Test Type
Not all STI tests carry the same turnaround expectation. Here's what the industry should deliver across the major test categories.
| Test Type | Expected TAT | Best-in-Class TAT | Key Delay Factors |
|---|---|---|---|
| NAAT (CT/NG/TV) — Send-Out | 24–72 hours | 12–24 hours | Transport distance, batching schedule |
| NAAT (CT/NG/TV) — Point-of-Care | 30–90 minutes | 30–45 minutes | Platform availability, staff training |
| HIV Antibody/Antigen (4th Gen) | 24–48 hours | Same-day (POC), 24 hrs send-out | POC availability, confirmatory testing workflow |
| Syphilis (RPR/VDRL + TP-PA) | 24–48 hours | 24 hours | Reflex confirmatory testing adds time |
| HSV Type-Specific IgG | 48–72 hours | 48 hours | Serology batch scheduling |
| Gonorrhea Culture (Sensitivities) | 3–5 days | 48–72 hours | Growth time is fixed; transport critical |
| Trichomonas NAAT (standalone) | 24–48 hours | 12–24 hours | Usually run on same platform as CT/NG |
📋 Key Distinction: Collection-to-Receipt vs. Receipt-to-Result
Some labs quote TAT from specimen receipt at their facility. Others quote from collection at the clinic site. These numbers can differ by 12–24 hours depending on your courier setup. Always clarify which clock is being measured — and demand both numbers in your SLA.
Common Causes of Lab TAT Delays — and How to Avoid Them
Most TAT overruns trace to a small set of preventable root causes. Understanding them lets you address the right lever — whether that's your internal process, your lab partner's operations, or your routing strategy.
Batching and Courier Schedule Gaps
The single largest TAT driver for clinics running high-volume send-out testing is courier batching. If your courier picks up once per day at 3 PM, specimens collected at 4 PM sit overnight before they even leave your building. Multiply that by transport time and you've already consumed 24 hours before the lab has touched the sample.
Fix: Negotiate courier pickup windows explicitly. Multiple daily pickups — or on-demand courier dispatch — can cut transport-phase TAT by 50%. Ask your lab partner whether they offer or subsidize local courier coverage.
Specimen Rejection
Rejected specimens reset the TAT clock entirely. A rejection received on day 2 means a redraw request, patient contact, rescheduled collection, and the full TAT cycle again — often adding 3–5 business days to total result delivery. Even a 3% reject rate on 500 monthly tests means 15 complete TAT resets per month.
Rejection causes are largely controllable: collection technique, transport media selection, labeling accuracy, cold chain maintenance. Labs with reject rates below 2% consistently train their clinic partners on collection best practices and provide standardized kit protocols. If your lab isn't offering this, ask why.
End-of-Day Lab Cutoffs
Most reference labs have a processing cutoff — a time after which specimens arriving that day are held for the next morning's run. For clinics in later time zones or with afternoon courier pickups, this means specimens routinely arriving just after the cutoff and gaining an extra 12–18 hours of processing delay. Labs with extended processing windows (cutoffs at 8–10 PM) materially reduce this risk. Ask for your lab's current cutoff time and factor it into your courier schedule decisions.
High Lab Capacity Utilization
Reference labs running near capacity slow down. Instrument queues lengthen, QC backlogs build, and result review gets deferred. A lab that runs at 85% capacity during a typical week may spike to 105% during a disease outbreak or respiratory illness season — and your TAT takes the hit without any SLA violation they're legally required to acknowledge.
This is the core argument for multi-lab routing. When one lab is congested, an intelligent routing system shifts volume to a partner running at 60% capacity. Your TAT stays consistent even when any individual lab is under pressure.
Inadequate Results Integration
Even when the lab finalizes a result quickly, reporting latency can delay delivery by hours. Fax-based result delivery, manual CSV uploads, or portals that require clinic staff to log in and pull results add delay that doesn't show up in the lab's internal TAT metrics — but absolutely shows up in your patient care workflow.
SLA Frameworks: What to Negotiate with Lab Partners
A verbal commitment to fast turnaround is not an SLA. An SLA is a contractual obligation with defined metrics, measurement methodology, and financial consequences for non-performance. Most labs will offer SLA language on request — but the default language protects the lab, not you.
Here's what a strong TAT SLA framework looks like, and what to watch for in the language.
Define the Clock Explicitly
Your contract should specify exactly when TAT begins and ends:
- Start: Lab-side receipt timestamp (scanned/logged on arrival) OR collection timestamp (if you're holding them to end-to-end accountability)
- End: Result release timestamp in your EHR or ordering system — not the time the result is finalized in their LIS
- Business hours vs. calendar time: "48 business hours" and "48 hours" are meaningfully different on weekends. Specify which applies to your volume.
Require Numeric SLA Tiers
Vague SLA language like "results delivered as quickly as possible" or "standard 2-day turnaround" is unenforceable. Demand numeric thresholds:
✓ TAT SLA Checklist — What Your Contract Should Include
Watch for These SLA Red Flags
Contract language that protects the lab at your expense often appears in specific forms:
- "Best effort" TAT — Has no legal teeth. If there's no numeric threshold and no penalty, it's marketing copy, not a commitment.
- TAT measured from receipt, not collection — Lets labs exclude all transport time from their reported TAT, making their numbers look better than your patients experience.
- SLA penalties only triggered by "material" breach — "Material" is left undefined, giving the lab discretion to contest any claim. Demand specific numeric thresholds for penalty triggers.
- Broad force majeure carve-outs — Some contracts include "demand surges" or "supply chain disruptions" as force majeure. These are foreseeable operational risks, not extraordinary events. Push back.
- SLA performance data on request only — If the lab won't commit to proactive monthly reporting, they probably aren't meeting their targets consistently.
Know What TAT You Should Be Getting
Tell us your test volume and current lab setup. We'll show you whether your current TAT is competitive — and what routing optimization could deliver.
How ClearLane's Routing Optimizes for Turnaround Time
ClearLane's routing engine treats TAT as a first-class variable — alongside cost per reportable result and reject rate — in every specimen assignment decision.
Real-Time Capacity and TAT Monitoring
Contracted TAT is a ceiling, not a floor. A lab that's guaranteed 48-hour TAT may routinely deliver in 18 hours when running at low utilization — and may creep to 44 hours when volume spikes. ClearLane tracks actual TAT performance by lab in real time, not just contracted commitments. When Lab A's rolling 7-day actual TAT starts trending toward its SLA ceiling, routing shifts volume toward Lab B — before the SLA is breached, not after.
Courier Window Optimization
The routing engine accounts for each lab's courier pickup windows when assigning specimens. A specimen ordered at 2:30 PM gets assigned to the lab whose next courier departure is earliest — not the lab that nominally has the best pricing. A $2 CPRR savings is erased immediately if it comes with a 16-hour transport delay.
Reject Rate as a TAT Proxy
Every rejected specimen is a TAT reset. Labs with high historical reject rates for specific specimen types (rectal swabs, urethral specimens, urine from pediatric patients) generate more TAT resets regardless of how fast their processing is. ClearLane routes based on per-lab, per-specimen-type reject history — not just aggregate reject rates — to minimize the probability of a clock reset before the specimen has even been processed.
Results in Your Workflow
Across a network routing 800+ STI NAAT tests per month through ClearLane:
- 24-hour result delivery achieved on >90% of tests vs. 65–75% for typical single-lab send-out arrangements
- TAT-driven rush surcharge reduction of 60–80% — fewer expedited orders because standard routing already hits clinical timelines
- TAT resets from rejections under 1.5% vs. 3–5% industry average
- Zero manual result chasing — results delivered via API integration to your EHR or portal automatically
Key Takeaways
- TAT has four phases, each with distinct failure modes: collection, transport, processing, and reporting. Each requires its own management approach.
- Industry benchmarks vary by test type. NAAT send-out should hit 24–48 hours; anything above 72 hours is uncompetitive. POC testing delivers 30–90 minutes in-clinic when available.
- Most TAT delays are preventable: batching gaps, courier schedules, lab capacity utilization, and specimen rejection are all manageable with the right lab partner and routing strategy.
- Your SLA must include numeric thresholds, defined clocks, and financial penalties. "Best effort" TAT language protects the lab, not your patients.
- Multi-lab routing is the structural answer to TAT consistency. It eliminates single-lab capacity risk, optimizes for real-time performance over contractual promises, and reduces TAT resets from rejections.
Evaluate your lab partners: Use the FQHC Lab Partner Evaluation Checklist to score vendors on TAT, reject rate, pricing transparency, and contract terms.
Understand the full cost picture: TAT SLAs and cost per reportable result are linked — understand both before signing. See our routing framework in the STI Lab Routing Guide.